Oncogene-induced cellular senescence (OIS) is a complex program that is triggered in response to aberrant activation of oncogenic signaling. Initially, OIS was thought to be a barrier to malignant transformation because of its suppression on cell proliferation. Later studies showed that senescence induced by oncogenes can also promote the initiation and development of cancer. The opposing effects of OIS occur through different combinations of downstream effectors as well as the interplay of senescent cells and the underlying OIS and the interaction between senescent cells and the microenvironment. We propose that targeting senescent cells may
Introduction
Cellular senescence was discovered by Leonard HAYFLICK and Paul MOORHEAD as "replicative senescence" and was demonstrated to be a con- [1] [2] [3] . Cellular senescence --cultured cells and tumor tissues [1] mutations in Ras - [3] ; the Ras -in vivo [4] -BRAF AKT E2F1 and cyclin E PTEN and NF1 [5] --Ras only occurred when Ras was [6] .
in vitro and in vivo which -- [7] that the tumor suppressors p53 and RB are two major intrin- [12] . In --senescent cells .
abnormal cells [15] . Senescence-associated secretory phenotype [16] --cer therapy [17] -- [18] or [13] - [21] [22] have - [23] .
RB and p53 are two major regulators in OIS [24] [25] [26] . The The DNA damage response is an omnipresent mechanism underlying OIS -. OIS [31] .
- [31] senescence occurred concurrently [32] [ 33] .
Autophagy is activated in senescent cells
-- [34] .
- [35] such stress [36] impact on OIS.
SASP enables the communication of senescent cells with the microenvironment
- [37] . The
BRAF

V600E
-induced senescence -BRAF V600E [38] while BRAF V600E -. Fac--and paracrine . [41] --. More- [42] . The transcriptional activ-- [42] .
[43]
-- [22] . - [7] . Immune cells RAS -tocytes [44] development wild-type p53 was detrimental to the chemotherapy response [46] .
OIS counteracts cancer progression
OIS promotes cancer development -- [47] .
- [16] in vivo
[13] [48] . Factors such [42] .
--. CCL2 secreted by senescent hepatocytes has also been reported to survival and early recurrence in hepatocellular carcinoma .
Targeting cellular senescence in cancer - [57] . Due to the complicated role communication between senescent cells and their microenvisenescence in cancer therapy. 
Concluding remarks
